Jove
Visualize
联系我们

相关概念视频

Next-generation Sequencing03:00

Next-generation Sequencing

87.7K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
87.7K
Genetic Screens02:46

Genetic Screens

4.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Confirmation of frameshift variants in the last exon of FGFR1 as a cause of multiple epiphyseal dysplasia.

European journal of human genetics : EJHG·2026
Same author

Trends in antibiotic prescribing patterns in sixteen in-center dialysis units.

Infection control and hospital epidemiology·2026
Same author

Expanding the ABCA2-associated neurodevelopmental phenotype.

HGG advances·2026
Same author

Reimagining Value-Based Kidney Care: What Lies Beyond the Advancing American Kidney Health Initiative?

Kidney360·2026
Same author

Genomics to enhance newborn screening?

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Ventricular Arrhythmias During Extracorporeal Circulatory Support for Cardiac Indications: Outcomes in a Single-Center Retrospective Cohort, 2020-2023.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 9, 2025

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

25.8K

使用基因组测序扩展新生儿查

Alban Ziegler1, Carrie Koval-Burt1, Denise M Kay2

  • 1Department of Pediatrics, Columbia University Irving Medical Center, New York, New York.

JAMA
|October 24, 2024
PubMed
概括

新生儿基因组查 (NBS) 在不同人群中是可行的,可以识别超出当前方法的可治疗疾病. 进一步的研究将评估对健康结果的概括性和影响.

更多相关视频

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.6K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.0K

相关实验视频

Last Updated: Jun 9, 2025

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

25.8K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.6K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.0K

科学领域:

  • 基因组学
  • 公共卫生
  • 新生儿医学

背景情况:

  • 传统的新生儿查 (NBS) 在识别所有遗传疾病方面存在局限性.
  • 在不同种族和族群中对NBS的基因组测序的可行性尚未得到充分理解.

研究的目的:

  • 在多元化的纽约市人口中评估基因组NBS的可接受性,可行性和结果.
  • 报告"对所有新生儿罕见疾病的基因组统一查" (GUARDIAN) 研究的初步结果.

主要方法:

  • 涉及156种早期遗传疾病的基因组测序和99种神经发育障碍的可选查.
  • 在纽约市招收了4000名来自不同种族背景的新生儿.
  • 收集家长报告的种族和民族数据.

主要成果:

  • 获得72.0%的同意率, 参与者反映了纽约市的多样性.
  • 测序成功完成率为99.6%.
  • 报告了3.7%的检查阳性率, 确定目前没有NBS的情况.

结论:

  • 针对性基因组测序在不同人群中是可行的.
  • 基因组NBS可以通过确定其他可治疗的疾病来补充现有的查.
  • 需要进一步的研究来确认其通用性和临床影响.